Literature DB >> 2332018

Growth hormone response to exercise in asthmatic and normal children.

I Amirav1, R J Dowdeswell, M Plit, V R Panz, B I Joffe, H C Seftel.   

Abstract

Maximal growth hormone (GH) increments following exercise were compared in asthmatic (n = 14) and normal (n = 8) children. Exercise, which consisted of 6 min ergometer cycling while breathing cold dry (CD) air, induced asthma in all asthmatic patients but not in normal subjects. Baseline plasma GH levels were similar in both groups. Following exercise, however, asthmatic patients had significantly higher mean GH increments than normal subjects (14.8 vs 4.9 ng/ml, P less than 0.025). To evaluate the possible role of bronchoconstriction in the GH response all subjects exercised again, this time while breathing warm humid (WH) air. Despite the absence of exercise-induced asthma (EIA) while breathing WH air, asthmatic patients still had significantly higher mean GH increments than normal subjects (9.2 vs 2.3 ng/ml, P less than 0.05). We conclude that some asthmatic children show excessive GH secretion after exercise regardless of inspired air conditions or the development of EIA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2332018     DOI: 10.1007/bf02009670

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  28 in total

1.  Alpha-adrenergic hyper-responsiveness in asthma.

Authors:  W R Henderson; J H Shelhamer; D B Reingold; L J Smith; R Evans; M Kaliner
Journal:  N Engl J Med       Date:  1979-03-22       Impact factor: 91.245

2.  New evidence for growth hormone modulation by the alpha-adrenergic system in man.

Authors:  I Lancranjan; P Marbach
Journal:  Metabolism       Date:  1977-11       Impact factor: 8.694

3.  The effect of adrenergic receptor blockade on the exercise-induced serum growth hormone rise in normals and juvenile diabetics.

Authors:  A P Hansen
Journal:  J Clin Endocrinol Metab       Date:  1971-11       Impact factor: 5.958

4.  Agnogenic and stimulus-initiated growth hormone release in man. A reappraisal and a multiple pool model of hormonal release.

Authors:  I Spitz; B Gonen; D Rabinowitz
Journal:  Johns Hopkins Med J       Date:  1972-08

5.  Respiratory heat loss in exercise-induced asthma. Measurement and clinical application.

Authors:  I Amirav; R J Dowdeswell; M Plit
Journal:  S Afr Med J       Date:  1986-02-15

6.  Guidelines for the methodology of exercise challenge testing of asthmatics. Study Group on Exercise Challenge, Bronchoprovocation Committee, American Academy of Allergy.

Authors:  P A Eggleston; R R Rosenthal; S A Anderson; R Anderton; C W Bierman; E R Bleecker; H Chai; G J Cropp; J D Johnson; P Konig; J Morse; L J Smith; R J Summers; J J Trautlein
Journal:  J Allergy Clin Immunol       Date:  1979-12       Impact factor: 10.793

7.  Exercise-induced asthma.

Authors:  S Godfrey
Journal:  Arch Dis Child       Date:  1983-01       Impact factor: 3.791

8.  Growth hormone regulation in two types of aerobic exercise of equal oxygen uptake.

Authors:  W P VanHelder; K Casey; R C Goode; W M Radomski
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1986

9.  Prevention of exercise-induced asthma by indoramin.

Authors:  S Bianco; J P Griffin; P L Kamburoff; F J Prime
Journal:  Br Med J       Date:  1974-10-05

10.  The effect of thymoxamine and cromolyn sodium on postexercise bronchoconstriction in asthma.

Authors:  K R Patel; J W Kerr; E B MacDonald; A M MacKenzie
Journal:  J Allergy Clin Immunol       Date:  1976-04       Impact factor: 10.793

View more
  2 in total

1.  Effects of exercise during normoxia and hypoxia on the growth hormone-insulin-like growth factor I axis.

Authors:  W Schmidt; S Doré; A Hilgendorf; S Strauch; R Gareau; G R Brisson
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1995

2.  Therapeutical doses of salbutamol inhibit the somatotropic responsiveness to growth hormone-releasing hormone in asthmatic children.

Authors:  E Ghigo; M R Valetto; L Gaggero; A Visca; F Valente; J Bellone; D Castello; F Camanni
Journal:  J Endocrinol Invest       Date:  1993-04       Impact factor: 4.256

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.